BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 29611775)

  • 1. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
    Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
    Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
    Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
    FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
    Chen M; Chen X; Wan Q
    Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
    Sun M; Yang P; Du L; Yang Y; Ye J
    PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
    Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
    Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
    Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
    Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.
    Ji L; Hou X; Liu W; Deng X; Jiang Z; Huang K; Li R
    Microb Pathog; 2018 Nov; 124():223-229. PubMed ID: 30149133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
    Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus.
    Li M; Yu D; Ni B; Hao F
    Mol Immunol; 2017 Jul; 87():94-101. PubMed ID: 28431280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
    Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
    J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
    Zhao M; Tan Y; Peng Q; Huang C; Guo Y; Liang G; Zhu B; Huang Y; Liu A; Wang Z; Li M; Gao X; Wu R; Wu H; Long H; Lu Q
    Nat Commun; 2018 Feb; 9(1):583. PubMed ID: 29422534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Th17 differentiation in aged mice is significantly associated with high IL-1β level and low IL-2 expression.
    Lim MA; Lee J; Park JS; Jhun JY; Moon YM; Cho ML; Kim HY
    Exp Gerontol; 2014 Jan; 49():55-62. PubMed ID: 24140620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
    Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
    Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.